CircRNA circYY1 (hsa_circ_0101187) Modulates Cell Glycolysis and Malignancy Through Regulating YY1 Expression by Sponging miR-769-3p in Breast Cancer

References

• Zhang M, Rosen JM. Developmental Insights into Breast Cancer Intratumoral Heterogeneity. Trends in Cancer. 2015;1(4):242–251. doi:10.1016/j.trecan.2015.10.00526753176
   PubMed Web of Science ®Google Scholar
• Januškevičienė I, Petrikaitė V. Heterogeneity of breast cancer: the importance of interaction between different tumor cell populations. Life Sci. 2019;239:117009. doi:10.1016/j.lfs.2019.11700931669239
   PubMed Web of Science ®Google Scholar
• Peng L, Jiang J, Tang B, Nice EC, Zhang Y-Y XN. Managing therapeutic resistance in breast cancer: from the lncRNAs perspective. Theranostics. 2020;10(23):10360–10377.32929354
   PubMed Web of Science ®Google Scholar
• Palomeras S, Ruiz-Martínez S, Puig T. Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance. Molecules. 2018;23:9.
   Web of Science ®Google Scholar
• DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin. 2017;67(6):439–448.28972651
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.31395983
   PubMed Web of Science ®Google Scholar
• Han B, Chao J, Circular YH. RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol Ther. 2018;187:31–44.29406246
   PubMed Web of Science ®Google Scholar
• Li W, Yang F-Q, Sun C-M, et al. T et al. circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma. Theranostics. 2020;10(10):4395–4409.32292503
   PubMed Web of Science ®Google Scholar
• Liang H-F, Zhang X-Z, Liu B-G, Jia G-T, Li W-L. Circular RNA circ-ABCB10 promotes breast cancer proliferation and progression through sponging miR-1271. Am J Cancer Res. 2017;7(7):1566–1576.28744405
   PubMed Web of Science ®Google Scholar
• Zhao C, Li L, Li Z, et al. A Novel Circular RNA hsa_circRPPH1_015 Exerts an Oncogenic Role in Breast Cancer by Impairing miRNA-326-Mediated ELK1 Inhibition. Front Oncol. 2020;10:906. doi:10.3389/fonc.2020.0090632670874
   PubMed Web of Science ®Google Scholar
• Xu J-Z, Shao -C-C, Wang X-J, et al. circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death Dis. 2019;10(3):175. doi:10.1038/s41419-019-1382-y30787278
   PubMed Web of Science ®Google Scholar
• Khachigian LM. The Yin and Yang of YY1 in tumor growth and suppression. Int J Cancer. 2018;143(3):460–465. doi:10.1002/ijc.3125529322514
   PubMed Web of Science ®Google Scholar
• Sarvagalla S, Kolapalli SP, Vallabhapurapu S. The Two Sides of YY1 in Cancer: a Friend and a Foe. Front Oncol. 2019;9:1230. doi:10.3389/fonc.2019.0123031824839
   PubMed Web of Science ®Google Scholar
• Liang F, Fu X, Wang L. miR-5590-3p-YY1 feedback loop promotes the proliferation and migration of triple-negative breast cancer cells. J Cell Biochem. 2019;120(10):18415–18424. doi:10.1002/jcb.2915831190375
   PubMed Web of Science ®Google Scholar
• Hays E, Bonavida B. YY1 regulates cancer cell immune resistance by modulating PD-L1 expression. Drug Resist Updat. 2019;43:10–28. doi:10.1016/j.drup.2019.04.00131005030
   PubMed Web of Science ®Google Scholar
• Qiao K, Ning S, Wan L, et al. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway. J Exp Clin Cancer Res. 2019;38(1):418. doi:10.1186/s13046-019-1421-731623640
   PubMed Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94. doi:10.1186/s12943-017-0663-228535767
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Venø MT, Kjems KJ. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. doi:10.1038/onc.2017.36128991235
   PubMed Web of Science ®Google Scholar
• Ganapathy-Kanniappan S, Geschwind J-FH. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12(1):152. doi:10.1186/1476-4598-12-15224298908
   PubMed Web of Science ®Google Scholar
• Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95(7):912–919. doi:10.1080/09553002.2019.158965330822194
   PubMed Web of Science ®Google Scholar
• Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27(1):441–464. doi:10.1146/annurev-cellbio-092910-15423721985671
   PubMed Web of Science ®Google Scholar
• Garcia SN, Guedes RC, Marques MM. Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics. Curr Med Chem. 2019;26(41):7285–7322.30543165
   PubMed Web of Science ®Google Scholar
• Feng Y, Xiong Y, Qiao T, Li X, Jia L, Han Y. Lactate dehydrogenase A: a key player in carcinogenesis and potential target in cancer therapy. Cancer Med. 2018;7(12):6124–6136.30403008
   PubMed Web of Science ®Google Scholar
• Zhong Y, Du Y, Yang X, et al. Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer. 2018;17(1):79.29626935
   PubMed Web of Science ®Google Scholar
• Xie F, Li Y, Wang M, et al. RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis. Mol Cancer. 2018;17(1):144.30285878
   PubMed Web of Science ®Google Scholar
• Luo E-C, Chang Y-C, Sher Y-P, et al. MicroRNA-769-3p down-regulates NDRG1 and enhances apoptosis in MCF-7 cells during reoxygenation. Sci Rep. 2014;4:5908.25081069
   PubMed Web of Science ®Google Scholar
• Wang K, Yang S, Gao Y, Zhang C, Sui Q. MicroRNA-769-3p inhibits tumor progression in glioma by suppressing ZEB2 and inhibiting the Wnt/β-catenin signaling pathway. Oncol Lett. 2020;19:1.
   Web of Science ®Google Scholar
• Ju Q, Zhao L, Gao J, et al. Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis. Chin J Cancer Res. 2019;31(3):533–546.31354222
   PubMed Web of Science ®Google Scholar
• Lee MH, Lahusen T, Wang RH, et al. 1 positively regulates BRCA1 and inhibits mammary cancer formation. Oncogene. 2012;31(1):116–127.21666725
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou L, Li Z, et al. YY1 suppresses FEN1 over-expression and drug resistance in breast cancer. BMC Cancer. 2015;15:50.25885449
   PubMed Web of Science ®Google Scholar